Logo image of IMKTA

INGLES MARKETS INC-CLASS A (IMKTA) Stock Fundamental Analysis

NASDAQ:IMKTA - Nasdaq - US4570301048 - Common Stock - Currency: USD

67.51  +0.52 (+0.78%)

After market: 67.51 0 (0%)

Fundamental Rating

4

IMKTA gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 40 industry peers in the Consumer Staples Distribution & Retail industry. IMKTA has only an average score on both its financial health and profitability. IMKTA does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

IMKTA had positive earnings in the past year.
IMKTA had a positive operating cash flow in the past year.
Each year in the past 5 years IMKTA has been profitable.
In the past 5 years IMKTA always reported a positive cash flow from operatings.
IMKTA Yearly Net Income VS EBIT VS OCF VS FCFIMKTA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

1.2 Ratios

Looking at the Return On Assets, with a value of 2.47%, IMKTA is in line with its industry, outperforming 47.50% of the companies in the same industry.
The Return On Equity of IMKTA (3.94%) is worse than 60.00% of its industry peers.
Looking at the Return On Invested Capital, with a value of 4.06%, IMKTA is doing worse than 62.50% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for IMKTA is in line with the industry average of 8.23%.
The last Return On Invested Capital (4.06%) for IMKTA is well below the 3 year average (10.21%), which needs to be investigated, but indicates that IMKTA had better years and this may not be a problem.
Industry RankSector Rank
ROA 2.47%
ROE 3.94%
ROIC 4.06%
ROA(3y)8.19%
ROA(5y)9.27%
ROE(3y)14.31%
ROE(5y)18.03%
ROIC(3y)10.21%
ROIC(5y)11.79%
IMKTA Yearly ROA, ROE, ROICIMKTA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20 25

1.3 Margins

IMKTA has a Profit Margin (1.14%) which is comparable to the rest of the industry.
In the last couple of years the Profit Margin of IMKTA has remained more or less at the same level.
IMKTA's Operating Margin of 2.20% is in line compared to the rest of the industry. IMKTA outperforms 47.50% of its industry peers.
IMKTA's Operating Margin has declined in the last couple of years.
IMKTA's Gross Margin of 23.50% is in line compared to the rest of the industry. IMKTA outperforms 50.00% of its industry peers.
In the last couple of years the Gross Margin of IMKTA has remained more or less at the same level.
Industry RankSector Rank
OM 2.2%
PM (TTM) 1.14%
GM 23.5%
OM growth 3Y-23.38%
OM growth 5Y-2.75%
PM growth 3Y-27.97%
PM growth 5Y-0.73%
GM growth 3Y-3.36%
GM growth 5Y-0.61%
IMKTA Yearly Profit, Operating, Gross MarginsIMKTA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20 25

6

2. Health

2.1 Basic Checks

IMKTA has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
The number of shares outstanding for IMKTA remains at a similar level compared to 1 year ago.
The number of shares outstanding for IMKTA has been reduced compared to 5 years ago.
IMKTA has a better debt/assets ratio than last year.
IMKTA Yearly Shares OutstandingIMKTA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M
IMKTA Yearly Total Debt VS Total AssetsIMKTA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

2.2 Solvency

An Altman-Z score of 4.31 indicates that IMKTA is not in any danger for bankruptcy at the moment.
IMKTA has a Altman-Z score (4.31) which is in line with its industry peers.
IMKTA has a debt to FCF ratio of 24.41. This is a negative value and a sign of low solvency as IMKTA would need 24.41 years to pay back of all of its debts.
IMKTA's Debt to FCF ratio of 24.41 is on the low side compared to the rest of the industry. IMKTA is outperformed by 70.00% of its industry peers.
IMKTA has a Debt/Equity ratio of 0.32. This is a healthy value indicating a solid balance between debt and equity.
IMKTA's Debt to Equity ratio of 0.32 is fine compared to the rest of the industry. IMKTA outperforms 62.50% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.32
Debt/FCF 24.41
Altman-Z 4.31
ROIC/WACC0.56
WACC7.3%
IMKTA Yearly LT Debt VS Equity VS FCFIMKTA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.3 Liquidity

IMKTA has a Current Ratio of 3.19. This indicates that IMKTA is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of IMKTA (3.19) is better than 95.00% of its industry peers.
IMKTA has a Quick Ratio of 1.46. This is a normal value and indicates that IMKTA is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.46, IMKTA belongs to the top of the industry, outperforming 90.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.19
Quick Ratio 1.46
IMKTA Yearly Current Assets VS Current LiabilitesIMKTA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

1

3. Growth

3.1 Past

The earnings per share for IMKTA have decreased strongly by -64.88% in the last year.
Measured over the past 5 years, IMKTA shows a small growth in Earnings Per Share. The EPS has been growing by 6.65% on average per year.
IMKTA shows a decrease in Revenue. In the last year, the revenue decreased by -7.79%.
IMKTA shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 6.06% yearly.
EPS 1Y (TTM)-64.88%
EPS 3Y-24.13%
EPS 5Y6.65%
EPS Q2Q%-52.38%
Revenue 1Y (TTM)-7.79%
Revenue growth 3Y4.18%
Revenue growth 5Y6.06%
Sales Q2Q%-2.65%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
IMKTA Yearly Revenue VS EstimatesIMKTA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B
IMKTA Yearly EPS VS EstimatesIMKTA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2019 2022 5 10

2

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 20.71, IMKTA is valued on the expensive side.
Compared to the rest of the industry, the Price/Earnings ratio of IMKTA is on the same level as its industry peers.
IMKTA is valuated rather cheaply when we compare the Price/Earnings ratio to 27.48, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 20.71
Fwd PE N/A
IMKTA Price Earnings VS Forward Price EarningsIMKTA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of IMKTA indicates a rather cheap valuation: IMKTA is cheaper than 82.50% of the companies listed in the same industry.
Based on the Price/Free Cash Flow ratio, IMKTA is valued a bit more expensive than the industry average as 72.50% of the companies are valued more cheaply.
Industry RankSector Rank
P/FCF 59.69
EV/EBITDA 6.18
IMKTA Per share dataIMKTA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 50 100 150 200 250

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)3.11
EPS Next 2YN/A
EPS Next 3YN/A

6

5. Dividend

5.1 Amount

IMKTA has a yearly dividend return of 0.98%, which is pretty low.
IMKTA's Dividend Yield is a higher than the industry average which is at 2.03.
With a Dividend Yield of 0.98, IMKTA pays less dividend than the S&P500 average, which is at 2.34.
Industry RankSector Rank
Dividend Yield 0.98%

5.2 History

The dividend of IMKTA has a limited annual growth rate of 0.12%.
IMKTA has paid a dividend for at least 10 years, which is a reliable track record.
IMKTA has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)0.12%
Div Incr Years0
Div Non Decr Years11
IMKTA Yearly Dividends per shareIMKTA Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6

5.3 Sustainability

IMKTA pays out 19.81% of its income as dividend. This is a sustainable payout ratio.
IMKTA's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP19.81%
EPS Next 2YN/A
EPS Next 3YN/A
IMKTA Yearly Income VS Free CF VS DividendIMKTA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M
IMKTA Dividend Payout.IMKTA Dividend Payout, showing the Payout Ratio.IMKTA Dividend Payout.PayoutRetained Earnings

INGLES MARKETS INC-CLASS A

NASDAQ:IMKTA (7/17/2025, 8:00:02 PM)

After market: 67.51 0 (0%)

67.51

+0.52 (+0.78%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupConsumer Staples Distribution & Retail
GICS IndustryConsumer Staples Distribution & Retail
Earnings (Last)05-08 2025-05-08/bmo
Earnings (Next)08-07 2025-08-07
Inst Owners92.45%
Inst Owner Change0%
Ins Owners0.08%
Ins Owner Change0%
Market Cap1.28B
Analysts84.44
Price TargetN/A
Short Float %5.23%
Short Ratio6.37
Dividend
Industry RankSector Rank
Dividend Yield 0.98%
Yearly Dividend0.65
Dividend Growth(5Y)0.12%
DP19.81%
Div Incr Years0
Div Non Decr Years11
Ex-Date07-10 2025-07-10 (0.165)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 20.71
Fwd PE N/A
P/S 0.24
P/FCF 59.69
P/OCF 6.54
P/B 0.82
P/tB 0.82
EV/EBITDA 6.18
EPS(TTM)3.26
EY4.83%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)1.13
FCFY1.68%
OCF(TTM)10.32
OCFY15.28%
SpS284.91
BVpS82.77
TBVpS82.77
PEG (NY)N/A
PEG (5Y)3.11
Profitability
Industry RankSector Rank
ROA 2.47%
ROE 3.94%
ROCE 5.36%
ROIC 4.06%
ROICexc 4.69%
ROICexgc 4.69%
OM 2.2%
PM (TTM) 1.14%
GM 23.5%
FCFM 0.4%
ROA(3y)8.19%
ROA(5y)9.27%
ROE(3y)14.31%
ROE(5y)18.03%
ROIC(3y)10.21%
ROIC(5y)11.79%
ROICexc(3y)11.97%
ROICexc(5y)12.99%
ROICexgc(3y)11.97%
ROICexgc(5y)12.99%
ROCE(3y)13.5%
ROCE(5y)15.58%
ROICexcg growth 3Y-23.42%
ROICexcg growth 5Y-0.13%
ROICexc growth 3Y-23.42%
ROICexc growth 5Y-0.13%
OM growth 3Y-23.38%
OM growth 5Y-2.75%
PM growth 3Y-27.97%
PM growth 5Y-0.73%
GM growth 3Y-3.36%
GM growth 5Y-0.61%
F-Score5
Asset Turnover2.16
Health
Industry RankSector Rank
Debt/Equity 0.32
Debt/FCF 24.41
Debt/EBITDA 2.07
Cap/Depr 139.43%
Cap/Sales 3.22%
Interest Coverage 250
Cash Conversion 80.23%
Profit Quality 34.67%
Current Ratio 3.19
Quick Ratio 1.46
Altman-Z 4.31
F-Score5
WACC7.3%
ROIC/WACC0.56
Cap/Depr(3y)141.53%
Cap/Depr(5y)130.04%
Cap/Sales(3y)2.93%
Cap/Sales(5y)2.85%
Profit Quality(3y)57.87%
Profit Quality(5y)73.45%
High Growth Momentum
Growth
EPS 1Y (TTM)-64.88%
EPS 3Y-24.13%
EPS 5Y6.65%
EPS Q2Q%-52.38%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-7.79%
Revenue growth 3Y4.18%
Revenue growth 5Y6.06%
Sales Q2Q%-2.65%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-49.02%
EBIT growth 3Y-20.18%
EBIT growth 5Y3.14%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-78.85%
FCF growth 3Y-32.19%
FCF growth 5Y0.76%
OCF growth 1Y-29.62%
OCF growth 3Y-5.01%
OCF growth 5Y4.42%